In summary, we have shown that elevated intracellular cAMP levels and activation of PKA may enhance the PPTase activity of SHP2, ultimately attenuating type I IFNs-induced activation of JAK/STAT signaling and the anti-proliferative action in HCC cells. The gene discussed is PTPN11; the disease is hepatocellular carcinoma.